Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of TruAlt Bioenergy
Quarter-by-quarter operating performance
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 197 | 388 | 415 | 907 | 304 | 115 | 713 | 596 |
| Expenses + | 184 | 371 | 291 | 753 | 262 | 119 | 579 | 477 |
| Operating Profit | 14 | 17 | 125 | 154 | 42 | -5 | 134 | 119 |
| OPM % | 7% | 4% | 30% | 17% | 14% | -4% | 19% | 20% |
| Other Income + | 15 | 17 | 15 | 14 | 23 | 15 | 18 | 31 |
| Interest | 35 | 34 | 36 | 39 | 38 | 39 | 40 | 44 |
| Depreciation | 16 | 16 | 18 | 18 | 21 | 21 | 22 | 23 |
| Profit before tax | -22 | -16 | 86 | 111 | 6 | -49 | 90 | 84 |
| Tax % | -0% | 15% | 13% | -1% | 18% | -23% | 23% | 27% |
| Net Profit + | -22 | -19 | 75 | 112 | 5 | -38 | 69 | 61 |
| EPS in Rs | -3.05 | -2.64 | 10.65 | 15.81 | 0.67 | -4.42 | 8.08 | 6.98 |
Financials of TruAlt Bioenergy
Annual income statement trend
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales + | 762 | 1,223 | 1,908 | 1,728 |
| Expenses + | 657 | 1,035 | 1,599 | 1,438 |
| Operating Profit | 105 | 188 | 309 | 290 |
| OPM % | 14% | 15% | 16% | 17% |
| Other Income + | 0 | 57 | 61 | 86 |
| Interest | 35 | 143 | 144 | 160 |
| Depreciation | 21 | 57 | 67 | 86 |
| Profit before tax | 49 | 45 | 159 | 130 |
| Tax % | 28% | 29% | 8% | 25% |
| Net Profit + | 35 | 32 | 147 | 97 |
| EPS in Rs | 5.81 | 5.21 | 20.76 | 11.19 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
Financials of TruAlt Bioenergy
Capital structure and asset base
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 61 | 61 | 71 | 86 |
| Reserves | 179 | 204 | 698 | 1,435 |
| Borrowings + | 1,150 | 1,685 | 1,557 | 1,652 |
| Other Liabilities + | 465 | 469 | 704 | 606 |
| Total Liabilities | 1,856 | 2,418 | 3,030 | 3,778 |
| Fixed Assets + | 1,302 | 1,427 | 1,826 | 2,185 |
| CWIP | 10 | 201 | 3 | 68 |
| Investments | 0 | 10 | 4 | 4 |
| Other Assets + | 545 | 780 | 1,197 | 1,521 |
| Total Assets | 1,856 | 2,418 | 3,030 | 3,778 |
Financials of TruAlt Bioenergy
Operating, investing and financing cash movement
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from Operating Activity + | 233 | 35 | 329 | -296 |
| Cash from Investing Activity + | -1,149 | -384 | -243 | -413 |
| Cash from Financing Activity + | 920 | 367 | 40 | 648 |
| Net Cash Flow | 5 | 19 | 126 | -62 |
| Free Cash Flow | -42 | -321 | 70 | -806 |
| CFO/OP | 222% | 21% | 106% | -99% |
Financials of TruAlt Bioenergy
Working capital efficiency and return ratios
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 41 | 89 | 65 | 86 |
| Inventory Days | 112 | 72 | 60 | 173 |
| Days Payable | 225 | 70 | 139 | 89 |
| Cash Conversion Cycle | -72 | 92 | -14 | 170 |
| Working Capital Days | 8 | -130 | -27 | 64 |
| ROCE % | 11% | 14% | 10% |
If you can provide a valid transcript or document, I will be happy to assist with your query. Key concall takeaways from Dwarikesh Sugar Industries Ltd's Q4…
The provided PDF page contains a "500 . Key concall takeaways from Dwarikesh Sugar Industries Ltd's Q3 FY23 earnings call — and how it ranks against sector…
Management is optimistic about sustaining EBITDA margins (12-14%) with profitable business mix. Key concall takeaways from Chamanlal Setia's Q1 FY27 earnings…
100 crores revenue in vegetables within 3 to 5 years. Key concall takeaways from Kaveri Seed Company Ltd's Q1 FY27 earnings call — and how it ranks against…